ESPR - Historical Earnings Price Analysis
Source: KlickAnalytics
2026-03-02 17:33:35 ET
Esperion Therapeutics, Inc. (ESPR) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Opening Gap Moves
Actual Earning Moves
Full story available on KlickAnalytics.com
Esperion Therapeutics Inc.
NASDAQ: ESPR
ESPR Trading
-6.28% G/L:
$2.685 Last:
3,477,657 Volume:
$2.72 Open:
ESPR Latest News
March 05, 2026 07:00:00 am
HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
March 03, 2026 06:00:00 am
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst(TM) (bumetanide nasal spray)
February 24, 2026 08:00:00 am
Esperion to Report Fourth Quarter and Full Year 2025 Financial Results on March 10
ESPR Stock Data
$804,448,466
234,999,359
0.16%
70
N/A
Pharmaceuticals
Healthcare
US
Ann Arbor
